<DOC>
	<DOCNO>NCT02439879</DOCNO>
	<brief_summary>Patients diabetic neuropathy total symptom score ( TSS ) &gt; 7 point invite open multicenter study . Patients free pain medication severe diabetic complication .Patients start alpha lipoic acid ( ALA ) 1800 mg 4 week . Patients decrease &gt; 3 point TSS randomly allocate 600 mg ALA ( ALA group ) medication ( ALA withdrawal ) 16 week . In visit investigator evaluate change TSS necessity rescue medication control symptom ( mainly pain ) . At end study investigator compare ALA ALA withdrawal group TSS level frequency use rescue medication . Physicians free manage glucose maintain Hba1c close ADA target ( HbA1c &lt; 7 % ) .</brief_summary>
	<brief_title>Alpha Lipoic Acid Treatment Diabetic Neuropathy</brief_title>
	<detailed_description>This trial conduct accordance Declaration Helsinki approve ethic committee Universidad Popular Autónoma del Estado de Puebla , Mexico . All participant provide write informed consent . Type 2 diabetic patient ( accord American Diabetes Association ( ADA ) criterion ) symptomatic diabetic sensorimotor polyneuropathy ( DSPN ) define presence neuropathic symptom ( pain , paresthesia , numbness ) invite participate open-label multicenter trial . Inclusion criterion : total symptom score ( TSS ) &gt; 7 point , HbA1c &lt; 10 % , serum creatinine &lt; 2 mg/dl . Exclusion criteria evidence active cardiovascular disease , malignancy , condition cause neuropathic pain , use analgesic , antidepressant , antiepileptic drug , medication aim relief neuropathic pain . In addition , child-bearing female patient use effective birth control method surveillance board-certified gynecologist exclude . Phase 1 . All patient meet inclusion criterion receive 600 mg alpha lipoic acid ( ALA ) ( Meda Pharma , Germany ) orally tid , 30 min main meal 4 week . During phase 1 , medication relief neuropathic pain allow . Each participate site charge maintain glycemic control base investigator 's judgment attempt patient treat accord american diabetes association ( ADA ) guideline . All patient see week , site visit , TSS assess along pill count ensure drug adherence , presence adverse event , need , treatment adjustment maintain glucose level within ADA target . Patients TSS reduction &gt; 3 point end phase 1 select proceed phase 2 study . Patients decrease &lt; 3 point TSS use neuropathic pain drug exclude study phase 2 . Phase 2 . Patients decrease ≥3 TSS point phase 1 randomized receive 600 mg ALA orally qd 16 week ALA withdrawal . Patients scheduled visit clinic every 2-3 week TSS , monofilament assessment . If need , patient prescribe analgesic rescue medication monitor visit . Primary endpoint change TSS two group study phase 2 frequency use rescue medication Neurological examination perform baseline phase 1 2 include monofilament test , vibration perception threshold ( VPT ) , ankle reflex . A 10g nylon monofilament ( Thio-Feel ® Meda Pharma , Germany ) apply four anatomical site foot ( 1st , 3rd 5th metatarsal head plantar surface distal hallux ) previously describe ( correct answer = 1 point , maximum 4 point foot ) . Eight correct answer consider normal , 1-7 correct answer indicate reduced monofilament sensation , absent sensation assume answer correct . VPT evaluate use 128-Hz tuning fork ( Thio-Vib ® , Meda Pharma , Germany ) apply bilaterally tip great toe . Responses categorize abnormal ( perception vibration ) , present ( examiner perceives vibration &lt; 10 second patient report disappearance vibration perception ) reduce ( examiner perceive vibration &gt; 10 sec patient report disappearance vibration perception ) . Ankle reflex grade normal , decreased , absent</detailed_description>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Type 2 diabetic patient ( accord American Diabetes Association ( ADA ) criterion ) Symptomatic diabetic polyneuropathy Total Symptom Score ( TSS ) &gt; 7 point , HbA1c &lt; 10 % , Serum creatinine &lt; 2 mg/dl . Active cardiovascular disease Malignancy Any condition cause neuropathic pain Use analgesic , antidepressant , antiepileptic drug , medication aim relief neuropathic pain . Childbearing female patient use effective birth control method surveillance boardcertified gynecologist</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>